Jam

Coca-Cola Consolidated (NASDAQ: COKE) declared a $0.25 per share quarterly dividend for Q3 2025, payable August 8 to shareholders of record by July 25. As the largest U.S. Coca-Cola bottler, it distributes over 300 beverage brands to 60 million consumers across 14 states and Washington D.C. Consistent dividends reflect its financial stability and dominant market position through exclusive bottling rights and extensive distribution reach. (66 words)

**Summary:**
Hyperscale Data (NYSE: GPUS) achieved 36 consecutive monthly dividend payments for its 13% Series D Preferred Stock ($0.270833 monthly per share). Management reaffirmed commitment to these distributions. The company is strategically pivoting to focus solely on data center operations via subsidiary Sentinum. It will spin off its subsidiary Ault Capital Group (involving lending, AI software, etc.) by December 2025, with Series F holders eligible to exchange shares. Bitcoin mining may continue within Sentinum.

PepsiCo partnered with streetwear brand Samii Ryan to launch a limited-edition Pepsi Wild Cherry capsule collection. Merging Y2K nostalgia with rodeo-inspired fashion, the line features denim jackets, graphic tees, and accessories adorned with cherry-red accents and reimagined Pepsi branding. Available exclusively online through SamiiRyan.com and select retailers for summer 2025, the collection blends beverage heritage with contemporary street style. Ryan stated it reflects shared values of joy and authenticity through bold design.

ZenaTech (ZENA) qualifies under new Pentagon expedited drone procurement policy eliminating Green/Blue UAS certification requirements. Following a July 2025 directive reclassifying Group 1-2 drones as expendable assets, commanders can now directly purchase ZenaTech’s combat-ready portfolio (ZenaDrone 1000, IQ Square, IQ Nano) for training and missions. The policy mandates experimental unit adoption by September 2025, squad-level use in FY2026, and full DoD training integration by 2027. AI-enabled drone capabilities include operations in GPS-denied areas. While accelerating market access, the expendable classification may pressure pricing and invite competition.

Creative Medical Technology (CELZ) secured USPTO patent allowance through 2040 for its ImmCelz™ therapy targeting heart failure and post-heart attack damage. The treatment, delivered via minimally invasive outpatient procedure, addresses a potential US patient population exceeding 11 million. While this significantly broadens the company’s regenerative medicine IP portfolio, the therapy remains in development and lacks FDA approval or current revenue.

Milestone Pharmaceuticals announced an underwritten public offering of common shares with Series A and Series B warrants, plus pre-funded warrants for certain investors. Proceeds will primarily fund the clinical development and U.S. commercial launch of its PSVT treatment candidate, etripamil, while covering working capital. TD Cowen, Piper Sandler, and Wells Fargo Securities are joint bookrunners, with H.C. Wainwright as lead manager. This financing supports Milestone’s transition toward commercialization, though it may dilute existing shareholders.

XPENG launches G6 and G9 electric SUVs in Europe featuring ultra-fast charging capabilities. The G9 achieves 525 kW peak charging power while the G6 reaches 451 kW, enabling 10-80% charge in just 12 minutes. Both offer premium features: G9 provides up to 585 km WLTP range, G6 delivers 535 km. Utilizing 800V architecture with 5C Supercharging AI Battery technology and military-grade safety systems, the models incorporate Qualcomm Snapdragon 8295 and NVIDIA Orin-X processors for advanced autonomy. Available in eight European countries, deliveries begin late summer 2025.

Aker Solutions reported robust Q2/H1 2025 results. Q2 EBITDA margin was 8.3%, EPS NOK 1.46, net cash NOK 2.1bn, with order intake NOK 10.9bn and backlog NOK 68.0bn. H1 EPS was NOK 2.81. Revenue rose to NOK 15.2bn in Q2, driven by Life Cycle growth despite renewables margin pressure. The CEO highlighted project milestones and tech advances (e.g., autonomous drones). The company maintains its 2025 guidance: revenue exceeding NOK 55bn and underlying EBITDA margin (ex-OneSubsea) of 7.0-7.5%.

Civista Bancshares (NASDAQ: CIVB) priced an offering of 3.29 million common shares at $21.25 each, aiming to raise ~$70 million. With an underwriters’ option, proceeds could reach $80.5 million. The capital, expected to close July 14, will fund organic growth and potential acquisitions in Midwest markets. Piper Sandler leads the transaction under Civista’s existing SEC shelf registration.

Faraday Future launches its FX Super One MPV and AI tech on July 17th. Concurrently, verified FFAI shareholders (as of July 10, 2025) gain exclusive pre-ordering access and tiered perks via Stockperks. These include a $3,500 purchase voucher for Futurist tier holders (1+ shares) and extensive benefits like lifetime warranty/maintenance for Prestige holders (100,000+ shares), alongside priority delivery and customization. Targeted US deliveries start late 2025. (98 words)